ReviewHealth economics review2026
A systematic review of modeling approaches to evaluate diagnostics programs for stable coronary heart disease: suggestions for future health economic models.
Review in Health economics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo critically review health economic models used to evaluate diagnostic strategies for stable coronary artery disease (CAD), with a focus on methodological characteristics in model development.
methodsA systematic literature review (SLR) was conducted across major electronic databases and health technology assessment (HTA) agency websites from inception to January 2025. Studies were independently screened using predefined criteria. Data extraction focused on general characteristics, model structure, approaches to uncertainty, model validation, and transparency. These aspects were then systematically described to identify common methodological characteristics and potential areas for improvement.
resultsSeventy articles were included, comprising 67 peer-reviewed publications and three HTA reports. Most studies were model-based (n = 46), and models were structured as decision tree models (n = 27), Markov models (n = 6), or hybrid approaches (n = 13). While only 18 studies explicitly justified their choice of model structure. Substantial heterogeneity was observed in key modeling assumptions, including time horizon, cycle length and data sources. Among studies using long-term Markov models (n = 19), none explicitly reported the use of half-cycle correction. Although most studies conducted sensitivity analyses (n = 56), approaches to uncertainty varied widely, and only seven models incorporated deterministic, probabilistic, and scenario analyses. Model validation was infrequently reported, with only two studies describing any formal validation activities. Overall, transparency was limited, as none of the studies provided sufficient technical documentation and reporting of model implementation tools was also incomplete (n = 28).
conclusionMethodological heterogeneity and incomplete reporting exit in economic evaluation of diagnostic strategies for stable CAD, which may affect their transparency and comparability. Future research may benefit from clearer model justification, more consistent reporting of key technical assumptions, and systematic approaches to uncertainty and validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.